ABOUT LIFE SCIENCES ANGEL NETWORK

OUR STORY

LSAN was founded in 2010 when Dr. Milena Adamian returned to New York after working in San Francisco with prominent life science angel groups. Upon discovering that New York was missing an organization focused on identifying and helping early stage life sciences companies grow, Milena founded LSAN.

In 2010 LSAN began its operations under the New York Academy of Sciences and became an independent entity in early 2012.

LSAN was founded with the understanding that to help our portfolio companies succeed we need to provide them with funding but also with operational support and an access to a broad network of healthcare investors, key opinion leaders, corporate players and other entrepreneurs.

GOALS

  • Uncover and evaluate early stage opportunities.
  • Fund, mentor and provide operational support to funded companies.
  • Build a life sciences entrepreneurial ecosystem in NYC by educating entrepreneurs and investors.

MISSION

Improve outcomes and processes in healthcare by funding promising start-ups with validated technologies.

VALUE PROPOSITION

CORPORATE INVESTORS

Access to potential new product pipeline
(external R&D)

INDIVIDUALS

Opportunity to invest in early-stage life sciences
companies and impact quality of healthcare

LAW FIRMS AND
INVESTMENT BANKERS

Access to deal flow

ENTREPRENEURS AND TECH
TRANSFER OFFICES

Access to alternative funding sources

In addition to traditional angel investors, Angel Network membership
is also attractive to healthcare practitioners who previously lacked exposure
to investment opportunities in areas of their primary interest.

SHORT AND LONG-TERM SUCCESS MEASURES

  • Becoming the invaluable organization for scientists, entrepreneurs, and investors in healthcare.
  • Completion of initial investment alone or by syndication.
  • Subsequent funding at increased valuation.
  • Exits for financed companies and return on the initial investment for angels (via licensing agreements or M&A).

INVESTMENT FOCUS AND SIZE

  • Focus areas: medical devices, diagnostics, and digital healthcare.
  • Average size of direct investment: $350K–1.5MM.
  • Geography and stage agnostic.
  • Larger investments are syndicated with our partner angel groups or venture funds.

LSAN PHILOSOPHY

We follow a traditional model of building innovative and profitable companies and providing them with:

  • Financial and operational support.
  • Sector-specific mentorship.
  • Access to a broad network of healthcare investors, key opinion leaders, corporate players and entrepreneurs.

OUR UNIQUE POSITION

  • Strong domain expertise in healthcare.
  • Broad network of healthcare professionals, entrepreneurs, and investors.
  • Alliances with corporations, hospital systems, angel groups and incubators.
  • Multi-disciplinary Screening Committee.
  • Access to funding sources (syndication & non-dilutive financing).
  • Full-time professional management.
  • Diversified investment approach.

OPERATINGS PRINCIPLES

  • Integrate the efforts of incubators, tech transfer offices from major universities and research centers and serial entrepreneurs.
  • Assist entrepreneurs in getting from the idea stage to financing.
  • Syndicate investments with existing life science and non-life science angel groups and venture funds.
  • Promote awareness of the opportunities in various healthcare sectors.
  • Educate and build the life sciences entrepreneurial community in NYC.

Contact Us

info@lsanfund.com
954 Lexington Av, #117, New York, NY 10021
Phone: 646-535-4494
Fax: 646-478-9316